China News Service, Beijing, September 27 (Reporter Zhang Su) In a gynecological development charity project initiated by the China Red Cross Foundation and others, Xiang Leihong, a professor at the Huashan Hospital affiliated to Fudan University, said that acne has an effect on polycystic ovary syndrome. PCOS) The clinical diagnosis of hyperandrogen patients plays an important role.

  Xiang Leihong explained that hyperandrogenemia is an important diagnostic feature of PCOS, and its evaluation requires comprehensive consideration of clinical manifestations and biochemical indicators.

Among them, the evaluation of clinical symptoms, especially acne and hirsutism, is considered to be a more reliable basis than biochemical tests.

  "Polycystic ovary syndrome is a common endocrine disease in women, but there are often delays in diagnosis and missed diagnosis. Therefore, timely detection of clinical symptoms is very important for early diagnosis." Xiang Leihong pointed out that acne is for patients with polycystic ovary syndrome and high androgen. The clinical diagnosis plays an important role.

  She also said that acne is closely related to the common menstrual and metabolic abnormalities in patients with polycystic ovary syndrome, and that attention should be paid to acne screening and diagnosis of women visiting the clinic.

  In order to promote the development of China's gynecological diagnosis and treatment level, in 2019, the China Red Cross Foundation and Bayer Healthcare Co., Ltd. jointly launched the "Enabling Her Strength-China Gynecology Development Public Welfare Project".

The project aims to invite well-known domestic experts to explain and share the diagnosis and treatment of gynecological endocrinology, and guide clinicians to diagnose and treat patients more accurately, quickly and efficiently in actual diagnosis and treatment, alleviate the suffering of patients, and benefit the majority of women.

  Beginning in 2021, the "Engage Her Strength-China Gynecology Development Public Welfare Project" will launch the "Female Hyperandrogenism" publicity day on the 28th of each month.

(over)